A comprehensive view of Johnson & Johnson Services Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Healthcare professionals rank AbbVie as top player in immunology, despite competition from Pfizer and J&J, according to ZoomRx analysis; AbbVie scored highest in innovation and patient centricity, while Pfizer and J&J ranked second and third respectively
Published:
April 19, 2024
by FiercePharma
|
Boston Scientific's Farapulse PulseSelect Pulsed-Field Ablation system gains foothold in the US PFA system market; J&J remains top player in electrophysiology devices market with 54% market share
Published:
April 19, 2024
by MarketLine
|
Australia: Johnson & Johnson Consumer Receives Patent for 'Personal hygiene product with a digital element'
Published:
April 19, 2024
by Australian Government
|
Australia Patent: JOHNSON & JOHNSON VISION CARE Files Application for 'SYSTEMS AND METHODS FOR PREDICTING MYOPIA RISK'
Published:
April 19, 2024
by Australian Government
|
Australia: Johnson & Johnson Consumer Receives Patent for 'Oral care cleaning system utilizing entrained fluid'
Published:
April 19, 2024
by Australian Government
|
Ask us about our Government & Public Policy market view